Reuters logo
5 months ago
BRIEF-Enrollment completed in Ligand's phase 2 trial of lgd-6972 in type 2 diabetes
February 27, 2017 / 2:47 PM / 5 months ago

BRIEF-Enrollment completed in Ligand's phase 2 trial of lgd-6972 in type 2 diabetes

1 Min Read

Feb 27 (Reuters) - Ligand Pharmaceuticals Inc:

* Enrollment completed in Ligand's phase 2 trial of lgd-6972 in type 2 diabetes

* Ligand Pharmaceuticals Inc - company expects to report topline results in September 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below